UC San Diego School of Medicine receives $6.1M to launch a new research center studying the effects of maternal antibiotic use on breast milk and infant health. The center is funded by National Institutes of Health, as part of their new Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub.
Related Articles

News
Selective, Toxin-Bearing Antibodies Could Help Treat Liver Fibrosis
July 12, 2021
sandiegobiotech
News
Comments Off on Selective, Toxin-Bearing Antibodies Could Help Treat Liver Fibrosis
UC San Diego researchers discovered that immunotoxins targeting the protein mesothelin prevent liver cells from producing collagen, a precursor to fibrosis and cirrhosis, in mouse models of human disease. Click here to view original post… […]

News
From Coffee Cart to Educational Computing Platform
January 20, 2022
sandiegobiotech
News, UCSD News
Comments Off on From Coffee Cart to Educational Computing Platform
In classic UC San Diego fashion, an overheard conversation at a campus coffee cart has turned into an interdisciplinary project that’s making computing-intensive coursework more exciting while saving well over $… […]

News
Qualcomm Institute-based Startup Receives Funding to Continue Development of Opioid Sensor
August 6, 2020
sandiegobiotech
News, UCSD News
Comments Off on Qualcomm Institute-based Startup Receives Funding to Continue Development of Opioid Sensor
CARI Therapeutics has received additional funding from the National Institute of Drug Abuse to refine their tiny implantable biosensor that could help combat the deadly and destructive opioid crisis in the United States.
[…]